Showing results (891-900 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|July 7, 2021
Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case reportQian Zeng, Han Gao, Longdan Zhang, et al.
Anti-Cancer Drugs|July 7, 2021
High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapyDavid Symeonidis, Georgios Papageorgiou, Alexandros Liatsos, et al.
Anti-Cancer Drugs|July 7, 2021
Efficacy and biomarker exploration of camrelizumab combined with apatinib in the treatment of advanced primary liver cancer: a retrospective studyZhiming Zeng, Yanfeng Jiang, Cuizhen Liu, et al.
Anti-Cancer Drugs|July 7, 2021
Effective treatment of a BRAF V600E-mutant epithelioid glioblastoma patient by vemurafenib: a case reportZhiying Lin, Haiyan Xu, Runwei Yang, et al.
Anti-Cancer Drugs|June 19, 2021
IL-12 inhibits postoperative residual tumor growth in murine models of sarcoma and renal carcinomaHuiqin Ding, Shoujun Yuan, Jiangang Wang, et al.
Anti-Cancer Drugs|November 13, 2020
Circ-ZNF124 downregulation inhibits non-small cell lung cancer progression partly by inactivating the Wnt/β-catenin signaling pathway via mediating the miR-498/YES1 axisFei Gao, Lin Jia, Jianjun Han, et al.
Anti-Cancer Drugs|February 4, 2020
Anticancer activity of a 1,4-dihydropyridine in DMBA-induced mouse skin tumor modelDebashri Manna, Shabnam Akhtar, Pragati Maiti, et al.
Anti-Cancer Drugs|February 4, 2020
Full-dose cisplatin chemotherapy combined with hemodialysis in a patient with impaired renal function and a mediastinal germ cell tumorNynke G L Jager, Vicdan Sari, Anneke M Westermann, et al.
Anti-Cancer Drugs|February 22, 2020
Investigation of the cytotoxic activity of two novel digitoxigenin analogues on H460 lung cancer cellsLaurita Boff, Lara Persich, Paula Brambila, et al.
Anti-Cancer Drugs|July 29, 2021
Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case reportShengnan Zheng, Huiying Li, Yongjuan Lin, et al.
Pageof 464